Clinical trial
Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™…
NCT00258882 · Sanofi Pasteur, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00258882 |
|---|---|
| Title | Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine |
| Official title | Post-licensure Safety Surveillance Study of Routine Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Adacel®) |
| Lead sponsor | Sanofi Pasteur, a Sanofi Company, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Pertussis |
| Intervention type | Biological |
| Interventions | Tetanus Toxoid, acellular pertussis, diphtheria toxoid |
| Enrollment | 327,293 |
| Start date | Jan 1, 2006 |
| Primary completion | Jul 1, 2011 |
| Completion | Dec 1, 2012 |
| First posted | Nov 28, 2005 |
| Last update posted | Jul 17, 2018 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: